Women in the study who were obese and taking GLP-1 weight loss medications were 30% less likely to develop breast cancer than other women.

A new GLP-1 medication in oral pill form, elecoglipron, could help to significantly reduce blood sugar levels and body weight in people with type 2 diabetes, trial results suggest.

GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week ...

GLP-1 drugs commonly used for weight loss and diabetes decreased the risk of cancer spreading in patients with several different types of tumors including breast and lung ...

Research found that the weight-loss medications may reduce the spread of several obesity-related cancers, including lung, ...

New research suggests GLP-1s may reduce the risks of blood clots and early death in people with both obesity and autoimmune ...

Some people taking GLP-1 drugs for diabetes and obesity experience mental health benefits—particularly a decrease in symptoms ...

Research presented at American Diabetes Association session shows why doctors need to counsel patients on weight loss effects ...

Use of GLP-1 drugs for diabetes or obesity early in the first trimester of pregnancy, before a woman realizes she is ...

A new analysis indicates that the use of GLP-1 drugs, including Ozempic and Mounjaro, early in pregnancy may not ...

Summary: Researchers unmasked an alternative biological pathway explaining how GLP-1 receptor agonist medications alleviate ...

Continuation of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) into early pregnancy seems not to be associated with ...